Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with PTGX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
PTGX
Protagonist Therapeutics, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
PTGX
Uncorrelated: r 0.11 · 499D.
No shared co-movers.
LLY, solid
PTGX, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,418.01
▲
+0.03%
· post 1,411.06
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
PTGX
Protagonist Therapeutics, Inc
Change
145.73
▲
+0.61%
· post 139.47
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$9.0B
Revenue
$213M
Q2 FY26
Revenue
$46M
FY25
vs
Compare
After hours
Nov 2 '26
delayed
LLY
ELI Lilly & Co
vs
PTGX
Protagonist Therapeutics, Inc
1,418.01
▲
+0.03%
post 1,411.06
delayed
Price
145.73
▲
+0.61%
post 139.47
delayed
$1.3T
Mkt cap
$9.0B
Q3 FY26
$24.4B
Revenue
$213M
Q2 FY26
FY25
$65.2B
Revenue
$46M
FY25
Change
Change
LLY
1,418.01
▲
+0.03%
vs
PTGX
145.73
▲
+0.61%
After hours
Nov 2 '26
delayed